Genmab — Maj 2020
-
"See “Business—License and Collaboration Agreements—Genmab Collaboration and License Agreement.” The agreement sets out a defined process to facilitate the divestment of Cami by licensing the rights thereto to a third party, subject to Genmab’s right of first opportunity to negotiate to acquire Cami in full. This process includes the opportunity for both parties to bid for the license rights alongside third parties."
-
"Both parties are required to use commercially reasonable efforts to complete and maximize the value obtained in this process. Therefore, our rights to Cami are subject to our collaboration and license agreement with Genmab, and there can be no assurance that we will apply for regulatory approval of or commercialize Cami."
-
Det er hvis meget normalt med sådan en rettighed. At både ADC og Genmab har rettighed til at byde på hele stoffet forud for en ekstern partner
-
Men en clinical hold med sjældne men alvorlige sygdom, så mudre det nok billedet ganske meget. At skulle smide et stort beløb upfront
for at købe den anden part ud -
Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-cMet Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion-Driven NSCLC https://cancerdiscovery.aacrjournals.org/content/early/2020/05/15/2159-8290.CD-20-0116?sf122466357=1 full article via sic-hub
-
-
Der kan være mange penge i covid-19-aktier https://www.marketwatch.com/story/sorrento-therapeutics-stock-soars-on-massive-volume-after-upbeat-report-on-covid-19-antibody-experiment-2020-05-15?siteid=yhoof2&yptr=yahoo sindsygt på preclinical resultater
-
Det er helt ude i hampen.
-
Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-cMet Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion-Driven NSCLC https://cancerdiscovery.aacrjournals.org/content/early/2020/05/15/2159-8290.CD-20-0116
-
Rapid response to single agent daratumumab is associated with improved progression-free survival in relapsed/refractory AL amyloidosis https://www.tandfonline.com/doi/abs/10.1080/13506129.2020.1765768?journalCode=iamy20
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind